tiprankstipranks
Trending News
More News >
Theravance Biopharma (TBPH)
NASDAQ:TBPH
US Market
Advertisement

Theravance Biopharma (TBPH) Income Statement

Compare
324 Followers

Theravance Biopharma Income Statement

Last quarter (Q3 2025), Theravance Biopharma's total revenue was $19.99M, an increase of 18.51% from the same quarter last year. In Q3, Theravance Biopharma's net income was $3.62M. See Theravance Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 64.38M$ 57.42M$ 51.35M$ 55.31M$ 71.86M
Gross Profit
$ 64.38M$ 16.80M$ -12.05M$ -138.35M$ 71.86M
Operating Expenses
$ 111.33M$ 72.84M$ 79.91M$ 119.44M$ 369.48M
Depreciation and Amortization
$ 3.62M$ 2.00M$ 3.04M$ 4.81M$ 6.97M
EBITDA
$ -38.45M$ -51.65M$ -76.08M$ -232.83M$ -287.82M
Operating Income
$ -46.95M$ -56.03M$ -91.96M$ -257.78M$ -297.63M
Other Income/Expenses
$ 2.33M$ 6.77M$ -858.00K$ -7.44M$ -5.72M
Pretax Income
$ -44.61M$ -49.27M$ -92.81M$ -265.22M$ -303.34M
Net Income
$ -56.42M$ -55.19M$ 872.13M$ -199.43M$ -278.02M
Per Share Metrics
Basic EPS
$ -1.15$ -1.00$ -1.26$ -2.87$ -4.46
Diluted EPS
$ -1.15$ -1.00$ -1.26$ -2.87$ -4.46
Weighted Average Shares Outstanding
48.85M 55.30M 73.59M 69.46M 62.34M
Weighted Average Shares Outstanding (Diluted)
48.85M 55.30M 73.59M 69.46M 62.34M
Currency in USD

Theravance Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis